In this study, along with several PARK2 deletions and duplications confirmed by independent gene dosage experiments, a total of 182 genomic duplications and 161 heterozygous/homozygous deletions were measured, but no statistically significant regions associated with PD were identified. This evidence concerns the gene PRKN and Parkinson disease.